These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24872339)

  • 1. Metabolic bone disease screening practices among U.S. neonatologists.
    Kelly A; Kovatch KJ; Garber SJ
    Clin Pediatr (Phila); 2014 Oct; 53(11):1077-83. PubMed ID: 24872339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic bone disease and bone mineral density in very preterm infants.
    Figueras-Aloy J; Álvarez-Domínguez E; Pérez-Fernández JM; Moretones-Suñol G; Vidal-Sicart S; Botet-Mussons F
    J Pediatr; 2014 Mar; 164(3):499-504. PubMed ID: 24331689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to use... alkaline phosphatase in neonatology.
    Tinnion RJ; Embleton ND
    Arch Dis Child Educ Pract Ed; 2012 Aug; 97(4):157-63. PubMed ID: 22761487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Bone Disease of Prematurity: Risk Factors and Associated Short-Term Outcomes.
    Avila-Alvarez A; Urisarri A; Fuentes-Carballal J; Mandiá N; Sucasas-Alonso A; Couce ML
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33321828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Metabolic Bone Disease of prematurity.
    Rayannavar A; Calabria AC
    Semin Fetal Neonatal Med; 2020 Feb; 25(1):101086. PubMed ID: 32081592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Osteopenia of prematurity--prophylaxis, diagnostics and treatment].
    Hitrova S; Slancheva B; Popivanova A; Vakrilova L; Pramatarova T; Emilova Z; Yarakova N
    Akush Ginekol (Sofiia); 2012; 51(7):24-30. PubMed ID: 23610914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteopenia of prematurity. Proposal for clinical-laboratory screening].
    Zecca E; Romagnoli C; Alecci MC; Gallini F; Maggio L; De Carolis MP; Vento G
    Minerva Pediatr; 1992; 44(1-2):5-10. PubMed ID: 1552878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone as a marker for metabolic bone disease of prematurity.
    Moreira A; Swischuk L; Malloy M; Mudd D; Blanco C; Geary C
    J Perinatol; 2014 Oct; 34(10):787-91. PubMed ID: 24875407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopenia of prematurity: a national survey and review of practice.
    Harrison CM; Johnson K; McKechnie E
    Acta Paediatr; 2008 Apr; 97(4):407-13. PubMed ID: 18363949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in bone health as assessed by the speed of sound in very low birth weight preterm infants.
    Tomlinson C; McDevitt H; Ahmed SF; White MP
    J Pediatr; 2006 Apr; 148(4):450-5. PubMed ID: 16647403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of osteopenia of prematurity in preterm infants without phosphate supplementation: A prospective, observational study.
    Angelika D; Ugrasena IDG; Etika R; Rahardjo P; Bos AF; Sauer PJJ
    Medicine (Baltimore); 2021 May; 100(18):e25758. PubMed ID: 33950963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does transient hypothyroxinemia influence metabolic bone disease of prematurity?
    Demirel U; Özek E; Bereket A; Demirel B; Topuzoğlu A; Akman İ
    J Matern Fetal Neonatal Med; 2013 Dec; 26(18):1844-9. PubMed ID: 23672243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United States neonatology practice survey: personnel, practice, hospital, and neonatal intensive care unit characteristics.
    Pollack LD; Ratner IM; Lund GC
    Pediatrics; 1998 Mar; 101(3 Pt 1):398-405. PubMed ID: 9481004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early elevated alkaline phosphatase as a surrogate biomarker of ongoing metabolic bone disease of prematurity.
    Motte-Signoret E; Jlassi M; Lecoq L; Wachter PY; Durandy A; Boileau P
    Eur J Pediatr; 2023 Apr; 182(4):1829-1837. PubMed ID: 36792831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic bone disease in preterm infants: Relationship between radiologic grading in the wrist and serum biochemical markers.
    You SK; Lee JE; Lee SM; Cho HH
    Diagn Interv Imaging; 2017 Nov; 98(11):785-791. PubMed ID: 28734779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of fibroblast growth factor-23 as an early marker of metabolic bone disease of prematurity.
    Llorente-Pelayo S; Docio P; Arriola S; Lavín-Gómez BA; García-Unzueta MT; Ballesteros MÁ; Cabero-Pérez MJ; González-Lamuño D
    BMC Pediatr; 2024 Jun; 24(1):418. PubMed ID: 38951759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of Criteria for Pasteurized Donor Human Milk Use: A Survey of U.S. Neonatal Intensive Care Unit Medical Directors.
    Hagadorn JI; Brownell EA; Lussier MM; Parker MG; Herson VC
    JPEN J Parenter Enteral Nutr; 2016 Mar; 40(3):326-33. PubMed ID: 25267184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative ultrasound and biochemical parameters for the assessment of osteopenia in preterm infants.
    Altuncu E; Akman I; Yurdakul Z; Ozdoğan T; Solakoğlu M; Selim N; Bilgen H; Ozek E; Bereket A
    J Matern Fetal Neonatal Med; 2007 May; 20(5):401-5. PubMed ID: 17674245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic bone disease of prematurity: report of four cases.
    Yeşiltepe Mutlu G; Kırmızıbekmez H; Ozsu E; Er I; Hatun S
    J Clin Res Pediatr Endocrinol; 2014; 6(2):111-5. PubMed ID: 24932605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prematurity and bone health.
    Pieltain C; de Halleux V; Senterre T; Rigo J
    World Rev Nutr Diet; 2013; 106():181-8. PubMed ID: 23428699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.